Advisors Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 254,836 shares of GILD stock, worth $23.4 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

254,836

Previous 273,732 6.9%

Holding current value

$23.4 Million

Previous $18.8 Million 13.74%

% of portfolio

0.4%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $1.26 Million - $1.59 Million	-18,896 Reduced 6.9%	254,836 $21.4 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $709,300 - $818,588	11,232 Added 4.28%	273,732 $18.8 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $838,774 - $1.02 Million	-11,718 Reduced 4.27%	262,500 $19.2 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $3.36 Million - $3.82 Million	-45,918 Reduced 14.34%	274,218 $22.2 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $2.12 Million - $2.42 Million	-27,918 Reduced 8.02%	320,136 $24.7 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $3,478 - $3,963	45 Added 0.01%	348,054 $28.9 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $1.61 Million - $2.31 Million	25,863 Added 8.03%	348,009 $29.9 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $1.1 Million - $1.26 Million	18,525 Added 6.1%	322,146 $19.9 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $1.99 Million - $2.24 Million	34,453 Added 12.8%	303,621 $18.8 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $1.15 Million - $1.44 Million	19,875 Added 7.97%	269,168 $16 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $1.31 Million - $1.49 Million	20,186 Added 8.81%	249,293 $18.1 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $1 Million - $1.08 Million	14,808 Added 6.91%	229,107 $16 Million
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $1.8 Million - $1.96 Million	28,290 Added 15.21%	214,299 $14.8 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $263,580 - $300,744	4,393 Added 2.42%	186,009 $12 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $136,413 - $155,436	-2,408 Reduced 1.31%	181,616 $10.6 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.17 Million - $1.48 Million	-18,903 Reduced 9.32%	184,024 $11.6 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $1.84 Million - $2.13 Million	-25,397 Reduced 11.12%	202,927 $15.6 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.59 Million - $2.04 Million	-25,411 Reduced 10.01%	228,324 $17.1 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.8 Million - $1.98 Million	29,197 Added 13.0%	253,735 $16.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.74 Million - $1.92 Million	27,824 Added 14.14%	224,538 $14.2 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.78 Million - $3.12 Million	44,964 Added 29.63%	196,714 $13.3 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $3.79 Million - $4.24 Million	60,575 Added 66.44%	151,750 $9.87 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $1.73 Million - $2.25 Million	28,507 Added 45.49%	91,175 $5.7 Million
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $4.1 Million - $4.54 Million	-57,510 Reduced 47.85%	62,668 $4.84 Million
Q2 2018 Aug 22, 2018	BUY	$64.88 - $75.68 $5.19 Million - $6.05 Million	79,960 Added 198.82%	120,178 $8.51 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $9.65 Million - $11.3 Million	-148,726 Reduced 78.71%	40,218 $8.51 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $258,290 - $314,884	-3,546 Reduced 1.84%	188,944 $14.9 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $51,228 - $60,134	720 Added 0.38%	192,490 $13.8 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $13.8 Million - $16.4 Million	191,770	191,770 $15.5 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Gilead Sciences, Inc. Transaction History